What makes this shortlist useful
Compare assessment scope, actual formulation, quantity, repeat-order rules and a method for reporting irritation or changed medical history. Current product names should match the ordering page. A personalized service should specify what arrives in the individual prescription rather than relying on a list of every ingredient it may use.
Read the full review →
1. CoreAge Rx Smooth Move: a defined ingredient family
Smooth Move lists tretinoin, niacinamide and vitamin C in a compounded cream supplied after physician review. The public ingredient panel does not identify one universal tretinoin concentration. A prescriber should explain the actual strength and introduction plan rather than the reader borrowing instructions from another product. CoreAge’s public panel identifies the main ingredient combination, with concentration left to confirm. Ask how the provider selects that strength and how a review affects the next cream order if tolerance or the treatment goal changes.
For CoreAge Rx Smooth Move, the consultation or label question is: What tretinoin concentration and application schedule will I receive, and how should I simplify my existing routine? An answer should clarify the product’s real role before it joins the routine; uncertainty is a reason to clarify, not to add another layer.
Read the full CoreAge Rx Smooth Move review →
2. Curology HydroTret Rx: personalized tretinoin with hydration positioning
Curology now presents HydroTret Rx at its former Future-Proof URL. The current page describes personalized tretinoin with hydrating dexpanthenol and provider-selected ingredients. The actual prescription determines the formulation, and a hydrating base does not guarantee that tretinoin will be irritation-free. The current HydroTret name and individualized actives make clear product identification essential. Ask who reviews response and how to obtain adjustments, rather than assuming hydration language removes the need for follow-up.
For Curology HydroTret Rx, the consultation or label question is: Which actives and tretinoin strength are in my personal formula, and how will dryness or intolerance be handled? An answer should clarify the product’s real role before it joins the routine; uncertainty is a reason to clarify, not to add another layer.
Read the full Curology HydroTret Rx review →
3. Agency Night Renew Rx: a current night-prescription service
Agency’s former Future Formula URL now presents Night Renew Rx. The service describes personalized tretinoin strengths and supporting ingredients. The current name matters, while the actual selected combination and instructions determine what a patient receives rather than every ingredient shown in marketing. Agency’s renamed product and personalized strengths can be compared on the actual care and supply arrangement. Confirm the selected formula, shipment interval and route to report irritation before accepting a recurring plan.
For Agency Night Renew Rx, the consultation or label question is: What is the precise Night Renew formula selected for me, and what adjustment support is available if it is too irritating? An answer should clarify the product’s real role before it joins the routine; uncertainty is a reason to clarify, not to add another layer.
Read the full Agency Night Renew Rx review →
4. Dermatica Personalized Formula: assessment-led formula selection
Dermatica’s personalized service links a skin assessment with a provider-selected prescription formula. The actual ingredients and strengths need confirmation in the individual plan. It is a service route distinct from the brand’s separately sold retail retinal and azelaic-acid products. Dermatica’s service separates personalized prescribing from its retail shop. Identify which pathway is being ordered, which ingredients are selected and what ongoing provider access is included in the actual plan.
For Dermatica Personalized Formula, the consultation or label question is: Which ingredients will my prescription actually contain, and how will the plan be reviewed if my skin becomes irritated? An answer should clarify the product’s real role before it joins the routine; uncertainty is a reason to clarify, not to add another layer.
Read the full Dermatica Personalized Formula review →
5. Hers Anti-Aging Rx Cream: a customized cream delivery route
Hers offers a customized compounded prescription anti-aging cream after clinician review. The actual ingredients and strengths depend on the selected plan. Its delivery pathway can be compared with other services, while the prescription itself should be evaluated separately from cosmetic retail retinol. Hers adds another prescription pathway whose full formula and order depend on assessment. Ask for the actual supply and communication route, keeping those facts separate from general promises about a customized anti-aging result.
For Hers Anti-Aging Rx Cream, the consultation or label question is: What exact concentrations are being prescribed, and how will provider support handle irritation or a change in the plan? An answer should clarify the product’s real role before it joins the routine; uncertainty is a reason to clarify, not to add another layer.
Read the full Hers Anti-Aging Rx Cream review →
Choose the next step, then confirm the order
The first shipment should include a clear label, directions and a way to ask questions. Put the review date beside the next refill date and clarify how the service handles a changed prescription. A convenient online route remains useful when it provides enough information to understand the treatment, not merely reorder it.
A compounded personalized formula is not FDA-approved as a finished product. Clinician access and a prescription label do not turn manufacturer marketing into independent comparative evidence. The publication does not claim a hands-on patient trial or an independently measured service-response ranking.
Read the full review →
Read the full review →
Sources and verification
Official product pages support product identity and advertised terms. Clinical sources provide general context. Provider claims are identified as claims; this article does not report a patient trial.
Fresh public-page research captured October 1, 2026 using TinyFish. Full capture records and page hashes are retained in the project research directory.